BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

188 related articles for article (PubMed ID: 3555278)

  • 1. A practical approach to immunophenotyping of lymphomas. Comparison of immunohistologic and immunocytologic techniques.
    Sun T; Susin M
    Ann Clin Lab Sci; 1987; 17(1):14-26. PubMed ID: 3555278
    [TBL] [Abstract][Full Text] [Related]  

  • 2. [Immunoperoxidase study of normal and pathologic lymphoid tissue. Value of monoclonal antibodies].
    Delsol G; Al Saati T; Caveriviere P; Voigt JJ; Ancelin E; Rigal-Huguet F
    Ann Pathol; 1984; 4(3):165-83. PubMed ID: 6383412
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Identification of two major B cell forms of nodular mixed lymphoma.
    Grogan TM; Hicks MJ; Jolley CS; Rangel CS; Jones SE
    Lab Invest; 1984 Nov; 51(5):504-14. PubMed ID: 6387274
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Immunohistochemical analysis of human lymphomas with monoclonal antibodies to B cell and Ia antigens reactive in paraffin sections.
    Marder RJ; Variakojis D; Silver J; Epstein AL
    Lab Invest; 1985 May; 52(5):497-504. PubMed ID: 3887032
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Reactivity of Leu 1 and T101 monoclonal antibodies with B cell lymphomas (correlations with other immunological markers).
    Al Saati T; Laurent G; Caveriviere P; Rigal F; Delsol G
    Clin Exp Immunol; 1984 Dec; 58(3):631-8. PubMed ID: 6239721
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Immunohistologic cellular phenotypes of lymphoproliferative disorders. Comprehensive evaluation of 564 cases including 257 non-Hodgkin's lymphomas classified by the International Working Formulation.
    Tubbs RR; Fishleder A; Weiss RA; Savage RA; Sebek BA; Weick JK
    Am J Pathol; 1983 Nov; 113(2):207-21. PubMed ID: 6605690
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [Immunocytologic diagnosis of leukemia and lymphoma: monoclonal antibodies in the differential diagnosis of hematologic neoplasms].
    Huber H; Gattringer C; Thaler J; Peschel C
    Behring Inst Mitt; 1985 Dec; (78):83-117. PubMed ID: 3914283
    [TBL] [Abstract][Full Text] [Related]  

  • 8. The demonstration of B-cell, T-cell and myeloid antigens in paraffin sections.
    West KP; Warford A; Fray L; Allen M; Campbell AC; Lauder I
    J Pathol; 1986 Oct; 150(2):89-101. PubMed ID: 3540244
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Practical approach to the immunodiagnosis of lymphomas emphasizing differential diagnosis.
    Warnke RA; Weiss LM
    Cancer Surv; 1985; 4(2):349-58. PubMed ID: 3879857
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Immunohistochemical staining of non-Hodgkin's lymphoma with monoclonal antibodies specific for the leucocyte common antigen.
    Salter DM; Krajewski AS; Dewar AE
    J Pathol; 1985 Aug; 146(4):345-53. PubMed ID: 2411901
    [TBL] [Abstract][Full Text] [Related]  

  • 11. The use of monoclonal antibodies in the diagnosis of peripheral T-cell lymphomas.
    Giraldo AA; Higgins MJ; Zielinska E; Humes JJ
    Ann Clin Lab Sci; 1987; 17(2):67-73. PubMed ID: 2953297
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Detailed phenotypic analysis of B-cell lymphoma using a panel of antibodies reactive in routinely fixed wax-embedded tissue.
    Norton AJ; Isaacson PG
    Am J Pathol; 1987 Aug; 128(2):225-40. PubMed ID: 3113255
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Two new monoclonal antibodies (LN-1, LN-2) reactive in B5 formalin-fixed, paraffin-embedded tissues with follicular center and mantle zone human B lymphocytes and derived tumors.
    Epstein AL; Marder RJ; Winter JN; Fox RI
    J Immunol; 1984 Aug; 133(2):1028-36. PubMed ID: 6376628
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Surface membrane phenotypic expression and treatment response of malignant lymphomas.
    Lauder I; Bird CC; Child JA; Grigor I
    J Pathol; 1985 Mar; 145(3):259-68. PubMed ID: 3920370
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [Immunophenotyping in the differential diagnosis of malignant non-hodgkin's lymphomas].
    Dzembak TM; Gurkalo VK; Gershanovich ML
    Vopr Onkol; 1996; 42(5):63-6. PubMed ID: 9064906
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Monoclonal antibody studies in B(non-T)-cell malignancies.
    Shimoyama M; Minato K; Tobinai K; Nagai M; Hirose M
    Jpn J Clin Oncol; 1983 Sep; 13(3):477-88. PubMed ID: 6417373
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Lineage differentiation of canine lymphoma/leukemias and aberrant expression of CD molecules.
    Wilkerson MJ; Dolce K; Koopman T; Shuman W; Chun R; Garrett L; Barber L; Avery A
    Vet Immunol Immunopathol; 2005 Jul; 106(3-4):179-96. PubMed ID: 15963817
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Lymphomas: membrane markers and cell flow cytometric diagnosis.
    Glassman AB; Self S; Christopher J
    Ann Clin Lab Sci; 1987; 17(1):1-7. PubMed ID: 3579204
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Phenotypic expression of non-Hodgkin's lymphomas in China.
    Xu LZ; Tu LY; Liu YF; Hsu SM; Qiu BS; Li ZX
    J Natl Cancer Inst; 1984 Sep; 73(3):635-8. PubMed ID: 6236322
    [TBL] [Abstract][Full Text] [Related]  

  • 20. The role of flow cytometry in the diagnosis of lymphoma: a critical analysis.
    Morse EE; Yamase HT; Greenberg BR; Sporn J; Harshaw SA; Kiraly TR; Ziemba RA; Fallon MA
    Ann Clin Lab Sci; 1994; 24(1):6-11. PubMed ID: 8147568
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.